NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

$875,000,000 for what exactly? And what should that make Advent / Sawston’s current worth?

>>Cognate operates an 80,000 square-foot site in Memphis, originally built in 2017 for autologous cell therapy manufacturing but now produces various cell types for customers’ clinical projects. “Our largest phase of clinical grade production was an autologous product for phase III clinical trials, mostly manufactured in Memphis with products shipped to more than 80 clinical sites in four countries,” the company states.

https://www.bioprocessintl.com/deal-making/cognate-buys-cobra-to-boost-gene-therapy-cdmo-capabilities